FI53703C - FREQUENCY REQUIREMENT FOR BETA-ADMINISTRATION BLOCKER AND 3,4-DIHYDROCARBOSTYRILDER - Google Patents

FREQUENCY REQUIREMENT FOR BETA-ADMINISTRATION BLOCKER AND 3,4-DIHYDROCARBOSTYRILDER

Info

Publication number
FI53703C
FI53703C FI279/73A FI27973A FI53703C FI 53703 C FI53703 C FI 53703C FI 279/73 A FI279/73 A FI 279/73A FI 27973 A FI27973 A FI 27973A FI 53703 C FI53703 C FI 53703C
Authority
FI
Finland
Prior art keywords
dihydrocarbostyrilder
blocker
beta
administration
frequency requirement
Prior art date
Application number
FI279/73A
Other languages
Finnish (fi)
Other versions
FI53703B (en
Inventor
Kazuyuki Nakagawa
Shiro Yoshizaki
Nanami Murakami
Hideo Mori
Michiaki Tominaga
Yasumitsu Tamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47092560A external-priority patent/JPS5246231B2/ja
Priority claimed from JP9255772A external-priority patent/JPS5324431B2/ja
Priority claimed from JP47092558A external-priority patent/JPS5241268B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Priority to FI770713A priority Critical patent/FI61894C/en
Publication of FI53703B publication Critical patent/FI53703B/fi
Application granted granted Critical
Publication of FI53703C publication Critical patent/FI53703C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
FI279/73A 1972-04-13 1973-01-31 FREQUENCY REQUIREMENT FOR BETA-ADMINISTRATION BLOCKER AND 3,4-DIHYDROCARBOSTYRILDER FI53703C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI770713A FI61894C (en) 1972-04-13 1977-03-07 SOM MELLANPRODUKTER ANVAENDBARA 1-SUBSTITUERADE ELLER 1-OSUBSTITUERADE 5- 6- 7- ELLER 8- (2,3-SUBSTITUERADE) -PROPOXI-3,4-DIHYDROXIKARBOSTYRILDERIVAT

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP47037182A JPS48103590A (en) 1972-04-13 1972-04-13
JP47037181A JPS517672B2 (en) 1972-04-13 1972-04-13
JP47092560A JPS5246231B2 (en) 1972-09-14 1972-09-14
JP9255772A JPS5324431B2 (en) 1972-09-14 1972-09-14
JP47092558A JPS5241268B2 (en) 1972-09-14 1972-09-14
JP47120953A JPS5229745B2 (en) 1972-04-13 1972-12-02
JP47125858A JPS5239036B2 (en) 1972-04-13 1972-12-14
JP47128972A JPS5241269B2 (en) 1972-04-13 1972-12-21

Publications (2)

Publication Number Publication Date
FI53703B FI53703B (en) 1978-03-31
FI53703C true FI53703C (en) 1978-07-10

Family

ID=27572212

Family Applications (1)

Application Number Title Priority Date Filing Date
FI279/73A FI53703C (en) 1972-04-13 1973-01-31 FREQUENCY REQUIREMENT FOR BETA-ADMINISTRATION BLOCKER AND 3,4-DIHYDROCARBOSTYRILDER

Country Status (17)

Country Link
JP (5) JPS48103590A (en)
AR (1) AR209575A1 (en)
AU (1) AU475964B2 (en)
BE (1) BE794669A (en)
CA (1) CA1025447A (en)
CH (1) CH575929A5 (en)
DD (2) DD108293A5 (en)
DE (1) DE2302027C2 (en)
DK (1) DK141603B (en)
FI (1) FI53703C (en)
FR (1) FR2179715B1 (en)
GB (2) GB1424571A (en)
HK (1) HK19481A (en)
NL (1) NL158176B (en)
NO (1) NO140589C (en)
SE (1) SE380018B (en)
YU (1) YU41187B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5082218A (en) * 1973-11-10 1975-07-03
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US4137331A (en) 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
JPS516971A (en) * 1974-07-08 1976-01-20 Otsuka Pharma Co Ltd Nitoro 3*44 jihidorokarubosuchirirujudotaino seizoho
JPS5129486A (en) * 1974-09-02 1976-03-12 Otsuka Pharma Co Ltd * 33 arukiruamino 22 hidorokishi * purohokishi 3 44 jihidorokarubosuchirirujudotai no seizoho
JPS5148674A (en) * 1974-10-17 1976-04-26 Otsuka Pharma Co Ltd 3 44 jihidorokarubosuchirirujudotaino seizoho
JPS5152178A (en) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd KARUBOSUCHIRIRU JUDOTAINO SEIZOHO
JPS5152180A (en) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd KARUBOSUCHIRIRU JUDOTAINO SEIZOHO
JPS5152179A (en) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd KARUBOSUCHIRIRU JUDOTAINO SEIZOHO
FI58329C (en) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd PROCEDURE FOR FRAMSTATION OF I 8-STATIONARY SUBSTITUTES 5- (3'-ALKYLAMINO-2'-HYDROXY) PROPOXI-3,4-DIHYDROCARBOSTYRILDER
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH619453A5 (en) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
GB1574665A (en) * 1976-05-08 1980-09-10 Otsuka Pharma Co Ltd 3,4-dihydrocarbostyril derivatives and process for preparing the same
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE2960178D1 (en) * 1978-06-06 1981-04-09 Hoechst Ag New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation
DE2827566A1 (en) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-DIHYDRO-CHINOLIN-2-ON DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DE3034237A1 (en) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo CARBOSTYRIL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTIHISTAMINICALLY ACTIVE AGENTS CONTAINING THESE COMPOUNDS
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS58103343A (en) * 1981-12-15 1983-06-20 Ota Seiyaku Kk Preparation of propanolamine compound
JPS597186A (en) * 1982-07-02 1984-01-14 Ota Seiyaku Kk 1,3,2-dioxathiolane 2-oxide derivative
JPS63193086U (en) * 1987-05-30 1988-12-13
DE3808136A1 (en) * 1988-03-11 1989-09-21 Thomae Gmbh Dr K DRUGS CONTAINING CHINOLINE-2,5-DIONE, NEW CHINOLINE-2,5-DIONE AND METHOD OF PREPARING THEM
US5266577A (en) * 1988-08-10 1993-11-30 Otsuka Pharmaceutical Company Ltd. Method of treating congestive heart failure using carbostyril derivatives
US5053514A (en) * 1988-08-10 1991-10-01 Otsuka Pharmaceutical Company, Limited Cardiotonics
WO1993004042A1 (en) * 1991-08-23 1993-03-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelet agglutination inhibitor
ES2048108B1 (en) * 1992-07-17 1994-10-01 Lusochimica Spa PROCEDURE FOR THE PREPARATION OF 5- (3-TERC-BUTILAMINO-2-HIDROXIPROPOXI) -3,4-DIHIDROCARBOESTIRILO.
IT1264816B1 (en) * 1993-07-28 1996-10-10 Pergam Srl Process for the preparation of 3,4-dihydrocarbostyryl derivatives
CZ300351B6 (en) * 2005-05-26 2009-04-29 Zentiva, A. S. Process for preparing 7-hydroxy-3,4-dihydrocarbostyril

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH523899A (en) * 1968-07-05 1972-06-15 Cassella Farbwerke Mainkur Ag 2-oxo-1,2-dihydroquinoline derivs

Also Published As

Publication number Publication date
HK19481A (en) 1981-05-22
NO140589B (en) 1979-06-25
DD108293A5 (en) 1974-09-12
FI53703B (en) 1978-03-31
JPS4976878A (en) 1974-07-24
JPS517672B2 (en) 1976-03-10
JPS48103589A (en) 1973-12-25
FR2179715B1 (en) 1976-12-03
JPS5229745B2 (en) 1977-08-03
JPS5241269B2 (en) 1977-10-17
JPS5239036B2 (en) 1977-10-03
GB1424572A (en) 1976-02-11
GB1424571A (en) 1976-02-11
AU475964B2 (en) 1976-09-09
JPS48103590A (en) 1973-12-25
NO140589C (en) 1979-10-03
JPS4981373A (en) 1974-08-06
SE380018B (en) 1975-10-27
DE2302027C2 (en) 1983-03-17
JPS4982673A (en) 1974-08-08
CA1025447A (en) 1978-01-31
AU5438673A (en) 1974-10-17
CH575929A5 (en) 1976-05-31
FR2179715A1 (en) 1973-11-23
AR209575A1 (en) 1977-05-13
YU41187B (en) 1986-12-31
YU254979A (en) 1982-10-31
DD112446A5 (en) 1975-04-12
DK141603C (en) 1980-10-06
DK141603B (en) 1980-05-05
NL158176B (en) 1978-10-16
NL7302353A (en) 1973-10-16
DE2302027A1 (en) 1973-12-06
BE794669A (en) 1973-05-16

Similar Documents

Publication Publication Date Title
FI53703C (en) FREQUENCY REQUIREMENT FOR BETA-ADMINISTRATION BLOCKER AND 3,4-DIHYDROCARBOSTYRILDER
FI55997C (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION 1,4-DIHYDROKARBOXYLSYRAESTRAR
FI55186B (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA OSYMMETRISKA 1,4-DIHYDROPYRIDINKARBOXYLSYRAESTRAR
ES188038Y (en) MUNECA AND SIMILAR.
BE800228A (en) HINGE, ESPECIALLY FOR FURNITURE
CA1011741A (en) 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides and related compounds
KE2930A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
FI56153B (en) SOEMLOES, TUNNVAEGGIG BEHAOLLARE AV PLASTMATERIAL
TR20457A (en) 1,2,3-TIYADIYAZOL DERIVES
FI55626C (en) PROCEDURE FOR FRAMSTAELLNING AV EN BEHAOLLARE
BE802531A (en) D-6-METHYL-ERGOLINES 2,8-DISUBSTITUTUEES
SE400768B (en) PROCEDURE FOR THE PREPARATION OF 2-PHENYL-6-SULFAMOYL-7-CHLORO-1,2,3,4-TETRAHYDRO-4-CHINAZOLINONE
SU479296A3 (en) The method of obtaining derivatives of 7-amino2n-1,4-benzodiazepin-2-one
BE789811A (en) 1,4-BIS-ACYLPIPERAZINES
FI56176C (en) PROCEDURE FOR FRAMSTAELLNING AV 2,4-DIAMINO-5-BENZYLPYRIMIDINE
PH9479A (en) 2,4-diamond quinazoline derivative
ZA738700B (en) Ethynylindenyl compounds and derivatives thereof
FI55847C (en) PROCEDURE FOR FRAMSTARING WITH SAOSOM DIURETTER AND SALURETER ANVAENDBARA SUBSTITUERADE 2,3-DIHYDRO-9-HYDROXI-P-DIOXINO- (2,3-G) KINOLINDERIVAT
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
FI55176B (en) FREQUENCY FRAMING FOR ISOPROPYLAMINERS
AT323631B (en) ANGLED
SE419980B (en) PROCEDURE FOR PREPARING SUBSTITUTED SUBSTITUTED 2-PHENYL-BICYCLO / 2,2,2 / OCT-3-YLALKYLAMINES
BR7301516D0 (en) D. YORK JR SET
FI55642C (en) FORM FOER FRAMSTAELLNING AV GLASPRODUKTER
FI52097C (en) Process for the preparation of 11-oxidized 2-chloro-6alpha, 9alpha-difluoro-16alpha-methyl-3,20,21-trioxo-1,4-pregnadienes and their α-acetates of 21-aldehyde hydrates.